The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 31 December 2024, approved the medicine tarlatamab ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved (27 December 2024) the medicine sotatercept ...

As the festive season approaches, experts have a warning for those taking prescription GLP-1 receptor agonist drugs.

John Marshall used to enjoy running but after a serious reaction to antibiotics in 2017 he was left barely able to walk. The 51-year-old from Kirkcaldy says his health changed dramatically after just ...

But instead of revealing the truth to the 17,000 people taking high doses and the other half-million Britons on a safer dose, the MHRA sat on its findings. Astonishingly, I was actually threatened ...

The MHRA has said the drugs had unpleasant side effects, and instructed doctors to ‘inform patients about the common and serious side effects associated with GLP-1RAs’. They were originally ...

Led by the Memorial Heights Redevelopment Authority (MHRA), the project also aims to decrease flooding and relieve traffic. Though it was intended to bring more people into the area, the Heights ...

The UK’s medicines regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA) said it is undertaking a review of safety warnings for 30 antidepressants including citalopram and prozac.

LEO Pharma has gained marketing authorisation from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) for its topical pan-Janus kinase (JAK) inhibitor, Anzupgo (delgocitinib ...

Credit: Kmpzzz/Shutterstock. Leo Pharma has gained marketing authorisation from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for its topical pan-Janus kinase (JAK) inhibitor, ...

Illustration by Rad Mora Supported by By The Styles Desk Style manifested in many forms over the last 12 months, as well as in many places: on the campaign trail and red carpets, at stadiums and zoos.